120 related articles for article (PubMed ID: 8535188)
1. Platelet derived growth factor expression, myelofibrosis and chronic myelogenous leukemia.
Kimura A; Katoh O; Hyodo H; Kuramoto A; Satow Y
Leuk Lymphoma; 1995 Jul; 18(3-4):237-42. PubMed ID: 8535188
[TBL] [Abstract][Full Text] [Related]
2. Platelet-derived growth factor expression in accelerated and blastic phase of chronic myelogenous leukaemia with myelofibrosis.
Kimura A; Nakata Y; Hyodo H; Kuramoto A; Satow Y
Br J Haematol; 1994 Feb; 86(2):303-7. PubMed ID: 8199019
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow trephine biopsy findings in chronic myeloid leukemia.
Khonglah Y; Basu D; Dutta TK
Malays J Pathol; 2002 Jun; 24(1):37-43. PubMed ID: 16329554
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary fibrosis with megakaryocytoid cell infiltration and chronic myelogenous leukemia.
Yamauchi K; Shimamura K
Leuk Lymphoma; 1994 Oct; 15(3-4):253-9. PubMed ID: 7866273
[TBL] [Abstract][Full Text] [Related]
5. Mixed phenotype (T/B/myeloid) extramedullary blast crisis as an initial presentation of chronic myelogenous leukemia.
Qing X; Qing A; Ji P; French SW; Mason H
Exp Mol Pathol; 2018 Apr; 104(2):130-133. PubMed ID: 29501750
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow core biopsy in 508 consecutive patients with chronic myeloid leukemia: Assessment of potential value.
Hidalgo-Lόpez JE; Kanagal-Shamanna R; Quesada AE; Gong Z; Wang W; Hu S; Medeiros LJ; Bassett RL; d'Orcy E; Yin CC; Cortes J; Jabbour EJ; Kantarjian HM; Bueso-Ramos CE
Cancer; 2018 Oct; 124(19):3849-3855. PubMed ID: 30321462
[TBL] [Abstract][Full Text] [Related]
7. Quantitative analysis of growth factor production in the mechanism of fibrosis in agnogenic myeloid metaplasia.
Wang JC; Chang TH; Goldberg A; Novetsky AD; Lichter S; Lipton J
Exp Hematol; 2006 Dec; 34(12):1617-23. PubMed ID: 17157157
[TBL] [Abstract][Full Text] [Related]
8. Megakaryopoiesis and myelofibrosis in chronic myeloid leukemia after allogeneic bone marrow transplantation: an immunohistochemical study of 127 patients.
Thiele J; Kvasnicka HM; Beelen DW; Flucke U; Spoer C; Paperno S; Leder LD; Schaefer UW
Mod Pathol; 2001 Feb; 14(2):129-38. PubMed ID: 11235904
[TBL] [Abstract][Full Text] [Related]
9. [Successful low-dose etoposide therapy for a case of myelofibrosis with chronic myelogenous leukemia megakaryocytic predominance type].
Katayama T; Masuoka H; Yoshida M; Watanabe R; Nishiwaki K; Shimada T; Kaito K; Ochiai S; Kobayashi M; Sakai O
Rinsho Ketsueki; 1992 Apr; 33(4):488-93. PubMed ID: 1602613
[TBL] [Abstract][Full Text] [Related]
10. Morphometric analysis of myelofibrosis in agnogenic myeloid metaplasia and chronic myelogenous leukemia.
Ohsaka A; Miura Y; Takahashi A; Yokoyama T
Virchows Arch B Cell Pathol Incl Mol Pathol; 1991; 60(6):399-405. PubMed ID: 1683056
[TBL] [Abstract][Full Text] [Related]
11. Connection between Parameters of Erythron System and Myelofibrosis during Chronic Myeloleukemia, Multiply Mieloma, and Chronic Lymphatic Leukemia.
Dolgikh TY; Sholenberg EV; Kachesov IV; Senchukova SR
Bull Exp Biol Med; 2018 Jan; 164(3):382-385. PubMed ID: 29308562
[TBL] [Abstract][Full Text] [Related]
12. Specific Features of Interactions between Megakaryocytic and Granulocytic Hematopoiesis Lineages and Myelofibrosis during the Acute Phase of Chronic Myeloid Leukemia, Chronic Lymphocytic Leukemia, and Multiple Myeloma.
Dolgikh TY; Senchukova SR; Vinogradova EV; Krinitsyna YM
Bull Exp Biol Med; 2020 Apr; 168(6):734-738. PubMed ID: 32333309
[TBL] [Abstract][Full Text] [Related]
13. [Differential analysis of BM cell morphology, immunophenotypic, cytogenetic characters and prognosis between myeloblastic and lymphoblastic crisis of CML].
Liu YL; Wang XN; Liu HS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):629-33. PubMed ID: 24989266
[TBL] [Abstract][Full Text] [Related]
14. Therapy-related changes of CD34+ progenitor cells in chronic myeloid leukemia: a morphometric study on sequential trephine biopsies.
Thiele J; Kvasnicka HM; Schmitt-Graeff A; Goekce D; Diehl V; Zankovich R; Schaefer HE
J Hematother Stem Cell Res; 2001 Dec; 10(6):827-36. PubMed ID: 11798509
[TBL] [Abstract][Full Text] [Related]
15. Correlation of marrow iron patterns with disease status of chronic myelogenous leukemia.
Welborn JL; Lewis JP
Leuk Lymphoma; 1993 Aug; 10(6):469-75. PubMed ID: 8401182
[TBL] [Abstract][Full Text] [Related]
16. [Basic and clinical study of platelet-derived growth factor gene expression].
Takimoto Y; Kimura A
Rinsho Ketsueki; 1994 Apr; 35(4):364-9. PubMed ID: 8028181
[TBL] [Abstract][Full Text] [Related]
17. The impact of megakaryocyte proliferation of the evolution of myelofibrosis. Histological follow-up study in 186 patients with chronic myeloid leukaemia.
Buhr T; Choritz H; Georgii A
Virchows Arch A Pathol Anat Histopathol; 1992; 420(6):473-8. PubMed ID: 1609507
[TBL] [Abstract][Full Text] [Related]
18. Chronic myelogenous leukemia in the lymphoid blastic phase: characteristics, treatment response, and prognosis.
Derderian PM; Kantarjian HM; Talpaz M; O'Brien S; Cork A; Estey E; Pierce S; Keating M
Am J Med; 1993 Jan; 94(1):69-74. PubMed ID: 8420302
[TBL] [Abstract][Full Text] [Related]
19. FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphocytic leukemia.
Neviani P; Santhanam R; Oaks JJ; Eiring AM; Notari M; Blaser BW; Liu S; Trotta R; Muthusamy N; Gambacorti-Passerini C; Druker BJ; Cortes J; Marcucci G; Chen CS; Verrills NM; Roy DC; Caligiuri MA; Bloomfield CD; Byrd JC; Perrotti D
J Clin Invest; 2007 Sep; 117(9):2408-21. PubMed ID: 17717597
[TBL] [Abstract][Full Text] [Related]
20. Blastic phase of chronic myelogenous leukemia.
Morris EL; Dutcher JP
Clin Adv Hematol Oncol; 2005 Jul; 3(7):547-52. PubMed ID: 16167037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]